Sugi Predict

Sugi Predict / Compounds / SCHEMBL900476

SCHEMBL900476

SCHEMBL900476

CCCCOc1cccc(C(c2nc3ccccc3s2)N(OC(=O)C(=O)ON(C2CCN(C)CC2)C(c2cccc(OCCCC)c2)c2nc3ccccc3s2)C2CCN(C)CC2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.41
▸ EBP Q15125 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41
▸ ATP4A P20648 4/20 0.38
▸ ATP4B P51164 4/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ LTA4H P09960 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL900475 0.79 MAPT (0.42) MAPTEBPSIGMAR1DRD2DRD3
SCHEMBL2720018 0.79 CYP2D6 (0.42) MAPTEBPSIGMAR1ATP4AATP4B
SCHEMBL16822332 0.78 MAPT (0.40) MAPTEBPSIGMAR1ATP4AATP4B
SCHEMBL900717 0.76 APEX1 (0.46) MAPTMEN1KMT2ANPC1ALDH1A1
SCHEMBL900449 0.75 CYP2D6 (0.42) MAPTEBPSIGMAR1DRD3MEN1
SCHEMBL900712 0.75 CYP2D6 (0.43) MAPTEBPSIGMAR1DRD3KMT2A
SCHEMBL2720478 0.74 EBP (0.42) MAPTEBPSIGMAR1ATP4AATP4B
SCHEMBL2720635 0.74 CHRM2 (0.39) MAPTEBPSIGMAR1DRD3MEN1
SCHEMBL899810 0.74 MAPT (0.43) MAPTEBPSIGMAR1MEN1KMT2A
SCHEMBL900504 0.74 MAPK1 (0.58) ATP4AATP4BMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 — — EP disclosed
US-9029357-B2 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2015-05-12 — — US disclosed
US-20150004181-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands BIOPROJET SOC CIV (FR) 2015-01-01 — — US disclosed
US-8802664-B2 Benzazole derivatives as histamine H4 receptor ligands BIOPROJECT (FR) 2014-08-12 — — US disclosed
US-20130231329-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands BIOPROJET (FR) 2013-09-05 — — US disclosed
EP-2621916-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2013-08-07 — — EP disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 — — EP disclosed
WO-2012041860-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2012-04-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004181-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands HRH4, HRH3, HRH2 MAPT 2901/4885EBP 2534/4885SIGMAR1 303/4885
US-20130231329-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands HRH4, HRH3, HRH2 MAPT 3180/4885EBP 1539/4885SIGMAR1 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.